These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34157315)

  • 1. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
    Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
    Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
    Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
    Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
    Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
    Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
    Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
    J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs in ovarian cancer.
    Zhan L; Li J; Wei B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):120. PubMed ID: 29921308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
    Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
    Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Long Non-Coding RNAs in Ovarian Cancer.
    Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
    Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
    Ghafouri-Fard S; Shoorei H; Abak A; Abbas Raza SH; Pichler M; Taheri M
    Biomed Pharmacother; 2021 Feb; 134():111172. PubMed ID: 33360156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
    Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
    Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential.
    Pandya G; Kirtonia A; Sethi G; Pandey AK; Garg M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188423. PubMed ID: 32871244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA landscape in triple-negative breast cancer.
    Zhang W; Guan X; Tang J
    Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
    Zou T; Wang PL; Gao Y; Liang WT
    Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.
    Oncul S; Amero P; Rodriguez-Aguayo C; Calin GA; Sood AK; Lopez-Berestein G
    RNA Biol; 2020 Nov; 17(11):1523-1534. PubMed ID: 31847695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.